CYR-241

N/A

Report date: 2025/01/15 11:21:46
NME

Base Information

Drug NameCYR-241
Drug Alias NameCYR-241CYR241
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunoglobulin G inhibitors
TargetsImmunoglobulin G
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyrus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyrus Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A